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The significance of foot care in diabetic patients is to salvage the limbs; that is, to prevent lower extremity
amputation (LEA). Diabetic foot ulcers (DFUs) precede most non-traumatic LEA. Foot care in diabetic patients
can therefore be split into two categories: foot care to prevent the development of DFUs; and wound care for pa-
tients who have already developed DFUs.
This review article provides an overview of the practice of foot care in diabetic patients. Next, based on a co-
hort study conducted in our department, risk factors for patients with DFUs were discussed. Predictors for the
incidence of LEA in patients with DFUs included malnutrition and peripheral arterial disease, and lower levels of
HDL cholesterol appeared to offer a novel clinical predictor. Moreover, mortality and severity of arteriosclerosis
among diabetic patients after LEA are related, and baPWV appears to represent the best noninvasive index of
the degree of arteriosclerosis.
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Fig.　1　Kaplan-Meier estimates of time to wound closure in the NPWT and pre-NPWT 
groups. Wound closure time was significantly shorter in the NPWT group than in the 
pre-NPWT group (log-rank test, p＝0.02). NPWT: negative-pressure wound therapy.



















































































Fig.　2　Cumulative incidence of the primary compos-
ite endpoint in two groups dichotomized by HDL 
cholesterol level at 40 mg/dL.
Primary composite endpoint: lower-extremity ampu-
tation or wound-related death.





















HDL cholesterol <40 mg/dL (n=86)









































































2004年 1月から 2014年 6月までに非外傷性下肢切
断を施行された糖尿病患者 102名（平均年齢 63歳）
を対象とした．平均 3.3年間の観察期間中 44名が死
亡した．1年生存率 84.9 %，2年生存率 73.5 %，5
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Fig.　3　Comparison of all-cause mortality rates among four groups classified into baPWV 
(above or below the median [21.8 m/s]) and ABI (normal [0.9-1.4] or abnormal). † p＜0.01 
versus patients with low baPWV and normal ABI; ‡ p＜0.01 versus patients with low 
baPWV and abnormal ABI. In the multivariate model, a stepwise variable-selecting pro-
cedure was applied. ABI and baPWV were incorporated into the model irrespective of 
p values. The following variables were used as covariates: age, sex, systolic blood pres-
sure, diastolic blood pressure, hemoglobin A1c, logarithmically transformed triglycerides 
level, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, presence 
of kidney dysfunction defined as estimated glomerular filtration rate＜60 mL/min/1.73 
m2 or dialysis, history of cardiovascular disease, history of leg revascularization, use of 
HMG-CoA reductase inhibitors (statins), use of angiotensin-converting enzyme inhibitors 
(ACEIs) or angiotensin II receptor blockers (ARBs), and amputation level (above ankle or 
not).
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